Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$22.17 - $51.8 $9,400 - $21,963
424 Added 1.43%
30,004 $1.55 Million
Q2 2022

Aug 12, 2022

BUY
$15.36 - $27.51 $42,608 - $76,312
2,774 Added 10.35%
29,580 $733,000
Q1 2022

May 13, 2022

SELL
$22.22 - $39.12 $41,951 - $73,858
-1,888 Reduced 6.58%
26,806 $672,000
Q4 2021

Feb 11, 2022

SELL
$18.38 - $40.5 $15,770 - $34,749
-858 Reduced 2.9%
28,694 $1.05 Million
Q3 2021

Nov 12, 2021

SELL
$13.18 - $19.83 $9,252 - $13,920
-702 Reduced 2.32%
29,552 $505,000
Q2 2021

Aug 13, 2021

BUY
$9.59 - $50.88 $12,975 - $68,840
1,353 Added 4.68%
30,254 $405,000
Q1 2021

May 07, 2021

BUY
$49.53 - $68.4 $3,764 - $5,198
76 Added 0.26%
28,901 $1.48 Million
Q4 2020

Feb 12, 2021

SELL
$47.25 - $65.16 $39,075 - $53,887
-827 Reduced 2.79%
28,825 $1.79 Million
Q3 2020

Nov 04, 2020

BUY
$46.35 - $61.69 $113,603 - $151,202
2,451 Added 9.01%
29,652 $1.63 Million
Q2 2020

Aug 12, 2020

BUY
$38.58 - $65.07 $118,903 - $200,545
3,082 Added 12.78%
27,201 $1.57 Million
Q1 2020

May 04, 2020

SELL
$32.73 - $50.78 $45,592 - $70,736
-1,393 Reduced 5.46%
24,119 $969,000
Q4 2019

Feb 05, 2020

SELL
$6.81 - $39.55 $1,464 - $8,503
-215 Reduced 0.84%
25,512 $1.01 Million
Q3 2019

Nov 08, 2019

SELL
$6.47 - $8.96 $1,164 - $1,612
-180 Reduced 0.69%
25,727 $174,000
Q2 2019

Aug 13, 2019

BUY
$8.31 - $14.85 $96,229 - $171,963
11,580 Added 80.83%
25,907 $241,000
Q1 2019

May 06, 2019

SELL
$10.01 - $13.89 $4,634 - $6,431
-463 Reduced 3.13%
14,327 $199,000
Q4 2018

Feb 13, 2019

SELL
$9.15 - $12.26 $1,043 - $1,397
-114 Reduced 0.76%
14,790 $161,000
Q3 2018

Nov 09, 2018

BUY
$10.49 - $13.72 $6,566 - $8,588
626 Added 4.38%
14,904 $188,000
Q2 2018

Aug 08, 2018

SELL
$10.62 - $13.98 $16,110 - $21,207
-1,517 Reduced 9.6%
14,278 $188,000
Q1 2018

May 07, 2018

SELL
$5.9 - $14.99 $5,009 - $12,726
-849 Reduced 5.1%
15,795 $215,000
Q4 2017

Feb 09, 2018

BUY
$5.53 - $8.42 $1,548 - $2,357
280 Added 1.71%
16,644 $99,000
Q3 2017

Nov 09, 2017

BUY
$6.5 - $10.69 $106,366 - $174,931
16,364
16,364 $121,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.